Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Topic Tracks*:

Organ Site Tracks*:

Showing session: reset

Harnessing Breakthroughs, Targeting Cures

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7
Transcriptional and epigenetic control of tumor cells
Richard A. Young
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
The two faces of p53: Tumor suppressor and oncogene
Carol L. Prives
Columbia Univ., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)
Richard S. Finn
UCLA, Los Angeles, CA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Discussant
José Baselga
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
New lymphoma therapies based on functional and structural genomics
Louis M. Staudt
NCI-CCR, Bethesda, MD, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Diet and cancer: Status report in 2014
Walter C. Willett
Harvard School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Tumor-specific immune activation: Immuno-oncology comes of age
Roger M. Perlmutter
Merck Research Laboratories, Rahway., NJ, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7